MNKD MannKind Corporation - Common Stock
MannKind Corporation - Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
और पढ़ें
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann.
History
Founded in February 1991, the company's present form is a result of a 2003 merger of three companies owned by Alfred E. Mann: Pharmaceutical Discovery Corporation (PDC), the cancer vaccine developer CTL ImmunoTherapies, Inc., and its sister company Allecure Corp, which was developing an allergy vaccine technology. Pharmaceutical Discovery was purchased in 2001 from Solomon Steiner; with that purchase MannKind acquired the Technosphere molecule and Medtone inhaler, upon which was developed its lead product, Afrezza (inhalable insulin).
The FDA approved Afrezza on June 27, 2014.
On August 11, 2014 MannKind entered into an exclusive global licensing agreement with Sanofi for Afrezza sales. Under the agreement, MannKind received $150 million cash from Sanofi, in exchange for sharing profits and losses of sales of Afrezza, with 65% for Sanofi and 35% for MannKind. On January 5, 2016, MannKind Corporation announced the termination of the license and collaboration agreement with Sanofi. By December 2017, the company had lost 11% of its trading volume due to the poor sales.
In March 2020, the company announced it was working with fellow pharmaceutical company Immix Biopharma to try to develop an inhalable treatment for acute respiratory distress syndrome, a lung disease.
Products and product candidates
The firm has developed Afrezza a rapid-acting insulin peaking 12 to 15 minutes after inhalation and exiting the body within 2–3 hours. The inhalation technology uses a miniature, breath-powered inhaler in combination with single-use cartridges containing pre-metered doses. Initial pharmacokinetic studies were followed by studies of safety and efficiency involving Technosphere formulations of different therapeutic proteins.
Leadership
Mann was chief executive officer until January 12, 2015 when Hakan Edstrom became CEO and Mann transitioned to executive chairman.
In November 2015, Hakan Edstrom stepped down as CEO and president. Company founder Alfred Mann stepped in as interim CEO on November 19, 2015. In 2016, Matthew Pfeffer was appointed CEO of MannKind, and served as both CEO and CFO. In May 2017, Michael Castagna was named CEO of the company.
Facilities
MannKind has a large corporate office in Westlake Village, California. The Afrezza manufacturing facility is in Danbury, Connecticut. In 2022, the company moved its official headquarters to Danbury.
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
MNKD स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
MNKD स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
MNKD विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
- मजबूत खरीद 4 28.6%
- खरीदें 8 57.1%
- होल्ड 2 14.3%
- बेचें 0 0.0%
- मजबूत बिक्री 0 0.0%
12-महीने का मूल्य लक्ष्य
8 विश्लेषक · 2026-08-17Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
| Period | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|
| 30 जून 2026 | $-0.06 | $-0.00 | -0.06% |
| 31 मार्च 2026 | $-0.05 | $-0.00 | -0.05% |
| 31 दिसमबर 2025 | $-0.05 | $0.01 | -0.06% |
| 30 सितमबर 2025 | $0.07 | $0.02 | 0.05% |
| 30 जून 2025 | $0.00 | $0.05 | -0.05% |
| 31 मार्च 2025 | $0.04 | $0.04 | -0.00% |
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| MNKD | $1.75B | 283.5 | 22.2% | 1.7% | -11.1% | — |
| NVAX | $1.09B | 2.6 | 64.7% | 39.2% | -977.1% | — |
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | — |
| GLUE | $1.03B | — | 63.5% | -31.2% | -15.4% | — |
| MGTX | $645M | -5.6 | 144.6% | -140.3% | 8062.2% | — |
| CRVS | $575M | -14.5 | — | — | -21.6% | — |
| REPL | $633M | -2.3 | — | — | -146.2% | — |
| VOR | $506M | -0.2 | — | — | 83.4% | — |
| SANA | $1.09B | -4.2 | — | — | -172.3% | — |
| SVRA | $1.23B | -11.4 | — | — | -73.4% | — |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण 16
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $349M | $286M | $199M | $100M | $75M | $65M | $63M | $28M | $12M | $175M | $0 | $0 | |
| Cost of Revenue | $27M | $17M | $21M | $16M | $17M | $15M | $20M | $19M | $17M | $17M | $65M | · | |
| SG&A Expense | $144M | $94M | $94M | $91M | $32M | $25M | $75M | $80M | $75M | $47M | $41M | $79M | |
| Operating Expenses | $88M | $77M | $63M | $57M | $39M | $25M | $108M | $104M | $120M | $107M | $345M | $180M | |
| Operating Income | $39M | $73M | $9M | $-64M | $-47M | $-48M | $-45M | $-77M | $-108M | $67M | $-345M | $-180M | |
| Interest Expense | · | · | $15M | $15M | $15M | · | · | · | · | · | $24M | $20M | |
| Interest Income | $8M | $13M | $6M | $3M | $112.0K | $167.0K | $997.0K | $501.0K | $293.0K | $85.0K | $18.0K | $9.0K | |
| Other Non-op | $-1M | $32.0K | $122.0K | $-102.0K | $-239.0K | $23.0K | $-926.0K | $-437.0K | $13.0K | $-597.0K | $1M | $2M | |
| Pretax Income | $1M | $31M | $-10M | $-87M | $-81M | $-57M | $-52M | $-87M | $-117M | $126M | $-368M | $-198M | |
| Income Tax | $-4M | $3M | $2M | $0 | $0 | $-218.0K | $0 | $240.0K | $51.0K | $0 | $0 | $0 | |
| Net Income | $6M | $28M | $-12M | $-87M | $-81M | $-57M | $-52M | $-87M | $-117M | $126M | $-368M | $-198M | |
| EPS (Basic) | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 | $-0.26 | · | $-0.60 | $-1.13 | $1.37 | $-4.54 | $-2.57 | |
| EPS (Diluted) | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 | $-0.26 | · | $-0.60 | $-1.13 | $1.36 | $-4.54 | $-2.57 | |
| Shares (Basic) | 305,639,000 | 274,415,000 | 267,014,000 | 257,092,000 | 249,244,000 | 222,585,000 | · | 144,136,000 | 104,245,000 | 92,053,000 | 81,233,000 | 77,045,000 | |
| Shares (Diluted) | 314,112,000 | 283,844,000 | 267,014,000 | 257,092,000 | 249,244,000 | 222,585,000 | · | 144,136,000 | 104,245,000 | 92,085,000 | 81,233,000 | 77,045,000 | |
| EBITDA | $39M | $73M | $9M | $-64M | $-47M | $-48M | $-45M | $-77M | $-106M | · | $-334M | $-170M |
बैलेंस शीट 28
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $75M | $46M | $238M | $70M | $124M | $67M | $30M | $71M | $44M | $23M | $59M | $121M | |
| Short-term Investments | $96M | $151M | $57M | $101M | $80M | $0 | $20M | · | · | · | · | · | |
| Receivables | $38M | $12M | $15M | $17M | $5M | $4M | $4M | $4M | $3M | $302.0K | $23.0K | $50M | |
| Inventory | $35M | $28M | $29M | $22M | $7M | $5M | $4M | $4M | $3M | $2M | · | $10M | |
| Prepaid Expense | $47M | $31M | $35M | $25M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $20M | |
| Current Assets | $292M | $268M | $373M | $235M | $219M | $79M | $61M | $82M | $57M | $77M | $77M | $201M | |
| PP&E (Net) | $82M | $85M | $84M | $45M | $37M | $26M | $27M | $26M | $27M | $29M | $49M | $192M | |
| PP&E (Gross) | $196M | $192M | $186M | $144M | $134M | $123M | $122M | $126M | $128M | $129M | $168M | $310M | |
| Accum. Depreciation | $114M | $107M | $102M | $99M | $98M | $97M | $95M | $100M | $101M | $100M | $120M | $118M | |
| Goodwill | $68M | $2M | $2M | $2M | · | · | · | · | · | · | · | · | |
| Intangibles | $5M | $5M | $1M | $1M | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $20M | $27M | $7M | $10M | $8M | $3M | $6M | $249.0K | $437.0K | $648.0K | $1M | $848.0K | |
| Total Assets | $792M | $394M | $475M | $295M | $321M | $109M | $94M | $108M | $85M | $107M | $126M | $394M | |
| Accounts Payable | $9M | $7M | $10M | $11M | $7M | $6M | $5M | $5M | $7M | $3M | $16M | $7M | |
| Accrued Liabilities | $65M | $40M | $42M | $36M | $27M | $20M | $16M | $15M | $12M | $8M | $8M | $26M | |
| Short-term Debt | · | · | · | · | · | · | $5M | · | · | · | · | · | |
| Current Liabilities | $171M | $82M | $104M | $67M | $48M | $74M | $66M | $75M | $88M | $92M | $268M | $403M | |
| Capital Leases | $11M | $12M | $4M | $5M | $1M | $1M | $3M | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | $5M | · | · | · | · | · | $15M | $12M | |
| Total Liabilities | $843M | $473M | $721M | $546M | $531M | $289M | $284M | $283M | $299M | $291M | $477M | $468M | |
| Long-term Debt | $355M | $36M | $269M | $273M | $281M | $122M | $119M | $102M | $157M | · | · | · | |
| Total Debt | · | · | · | · | · | · | $5M | · | · | · | · | · | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $957.0K | $4M | $4M | |
| Retained Earnings | $-3.20B | $-3.20B | $-3.23B | $-3.22B | $-3.13B | $-3.05B | $-2.99B | $-2.94B | $-2.85B | $-2.74B | $-2.86B | $-2.49B | |
| AOCI | $115.0K | $1M | · | · | · | · | $-19.0K | $-19.0K | $-18.0K | $-24.0K | $-20.0K | $-14.0K | |
| Stockholders' Equity | $-51M | $-79M | $-246M | $-251M | $-209M | $-180M | $-191M | $-175M | $-215M | $-184M | $-350M | $-74M | |
| Liabilities + Equity | $792M | $394M | $475M | $295M | $321M | $109M | $94M | $108M | $85M | $107M | $126M | $394M | |
| Shares Outstanding | 307,832,587 | 302,959,782 | 270,034,495 | 263,793,305 | 251,477,562 | 242,117,089 | 211,787,573 | 187,029,967 | 119,053,414 | 95,680,831 | 85,734,188 | 406,059,089 |
नकदी प्रवाह 18
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $7M | $5M | $3M | $2M | $2M | $972.0K | $3M | $2M | $2M | $11M | $10M | |
| Stock-based Comp | $24M | $21M | $18M | $13M | $12M | $7M | $6M | $7M | $5M | $5M | $9M | $49M | |
| Deferred Tax | $-19M | $4M | $7M | $-10M | $-20M | $-5M | $-5M | $-11M | $-260M | $48M | $-80M | $-66M | |
| Amort. of Intangibles | $4M | · | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | · | · | · | · | · | · | · | · | · | $2M | $6M | $2M | |
| Other Non-cash | · | · | · | · | · | · | · | · | $306M | · | $291M | $144M | |
| Operating Cash Flow | $18M | $43M | $34M | $-81M | $-62M | $-28M | $-88M | $-38M | $-65M | $-78M | $-57M | $4M | |
| CapEx | $5M | $10M | $42M | $8M | $11M | $801.0K | $3M | $354.0K | · | $1M | $10M | $24M | |
| Investing Cash Flow | $-305M | $-97M | $-2M | $5M | $-152M | $15M | $-23M | $-234.0K | $17M | $-1M | · | · | |
| Debt Issued | · | · | · | · | · | $5M | · | · | · | · | · | $20M | |
| Net Debt Issued | · | · | · | · | · | $5M | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | $564.0K | $893.0K | $28M | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $564.0K | · | $28M | · | |
| Financing Cash Flow | $315M | $-137M | $137M | $21M | $270M | $50M | $70M | $61M | $74M | $43M | · | · | |
| Net Change in Cash | $29M | $-191M | $169M | $-54M | $57M | $37M | $-41M | $23M | $25M | $-36M | $-62M | $50M | |
| Taxes Paid | $2M | $4M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $14M | $33M | $-8M | $-88M | $-73M | $-29M | $-91M | $-38M | · | · | $-68M | $-20M | |
| Levered FCF | · | · | $-26M | $-98M | · | · | · | · | · | · | $-92M | · |
लाभप्रदता 7
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% | -73.6% | -70.8% | -274.9% | -921.1% | · | · | · | |
| Net Margin | 1.7% | 9.7% | -6.0% | -87.6% | -107.3% | -87.9% | -82.3% | -312.2% | -999.0% | · | · | · | |
| Pretax Margin | 0.40% | 10.7% | -5.2% | -87.6% | -107.3% | -88.2% | -82.3% | -311.3% | -998.6% | · | · | · | |
| EBITDA Margin | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% | -73.6% | -70.8% | -274.9% | -905.8% | · | · | · | |
| ROA | 0.99% | 6.3% | -3.1% | -28.4% | -37.7% | -56.6% | -51.5% | -90.5% | -122.4% | · | -141.5% | -60.8% | |
| ROE | -11.1% | -19.1% | 4.8% | 35.8% | 41.1% | 31.2% | 27.7% | 45.7% | 58.9% | · | 173.8% | 379.7% | |
| ROIC | -316.9% | -83.2% | -4.1% | 25.6% | 22.5% | 26.5% | 24.0% | 43.9% | 50.4% | · | 98.4% | · |
तरलता और शोधन क्षमता 4
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 3.3 | 3.6 | 3.5 | 4.5 | 1.1 | 0.9 | 1.1 | 0.7 | · | 0.3 | 0.5 | |
| Quick Ratio | 1.2 | 2.6 | 3.0 | 2.8 | 4.3 | 1.0 | 0.8 | 1.0 | 0.5 | · | 0.2 | 0.4 | |
| Debt / Equity | · | · | · | · | · | · | -0.0 | · | · | · | · | · | |
| Interest Coverage | · | · | 0.6 | -6.7 | · | · | · | · | · | · | -14.3 | -8.8 |
दक्षता 3
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.7 | 0.5 | 0.3 | 0.4 | 0.6 | 0.6 | 0.3 | 0.1 | · | 0.0 | · | |
| Inventory Turnover | 0.8 | 0.6 | 0.8 | 1.1 | 2.8 | 3.3 | 5.2 | 6.2 | 6.9 | · | · | · | |
| Receivables Turnover | 13.9 | 21.4 | 12.6 | 9.3 | 16.4 | 16.9 | 16.7 | 8.2 | 7.6 | · | 0.0 | · |
विकास दरें 5
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 22.2% | 43.5% | 99.4% | 32.2% | 15.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 51.8% | 55.8% | 45.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 39.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -80.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -78.8% | · | · | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM) 13
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $349M | $286M | $199M | $100M | $75M | $65M | $63M | $28M | $12M | $175M | $0 | $0 | |
| Net Income TTM | $6M | $28M | $-12M | $-87M | $-81M | $-57M | $-52M | $-87M | $-117M | $126M | $-368M | $-198M | |
| Market Cap | $1.75B | $1.95B | $983M | $1.39B | $1.10B | $758M | $273M | $198M | $276M | · | $3.11B | $10.60B | |
| Enterprise Value | · | · | · | · | · | · | $228M | · | · | · | · | · | |
| P/E | 283.5 | 64.3 | -91.0 | -15.5 | -13.7 | -12.0 | -2.0 | -1.8 | -2.1 | 2.4 | -1.6 | -10.2 | |
| P/S | 5.0 | 6.8 | 4.9 | 13.9 | 14.6 | 11.6 | 4.3 | 7.1 | 23.5 | · | · | · | |
| P/B | -34.2 | -24.7 | -4.0 | -5.5 | -5.2 | -4.2 | -1.4 | -1.1 | -1.3 | · | -8.9 | -143.7 | |
| P / Cash Flow | 95.6 | 45.8 | 28.8 | -17.2 | -17.8 | -26.9 | -3.1 | -5.3 | -4.3 | · | -54.3 | 2593.8 | |
| P / FCF | 127.5 | 59.4 | -117.8 | -15.7 | -15.0 | -26.2 | -3.0 | -5.2 | · | · | -46.0 | -529.6 | |
| EV / EBITDA | · | · | · | · | · | · | -5.1 | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | · | -2.5 | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | 3.6 | · | · | · | · | · | |
| Earnings Yield | 0.35% | 1.6% | -1.1% | -6.5% | -7.3% | -8.3% | -48.8% | -56.6% | -48.7% | 42.5% | -62.6% | -9.8% |
आय विवरण 16
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $109M | $90M | $112M | $82M | $77M | $78M | $77M | $70M | $72M | $66M | $58M | $51M | $49M | $41M | $36M | $33M | |
| Cost of Revenue | $14M | $8M | $14M | $4M | $5M | $4M | $5M | $3M | $6M | $4M | $6M | $4M | $5M | $6M | $4M | $5M | |
| SG&A Expense | $58M | $54M | $58M | $29M | $32M | $25M | $24M | $24M | $24M | $22M | $61M | $11M | $12M | $11M | $64M | $9M | |
| Operating Expenses | $30M | $92M | $-103M | $63M | $21M | $56M | $-86M | $57M | $56M | $50M | $18M | $14M | $14M | $16M | $16M | $17M | |
| Operating Income | $-350.0K | $-2M | $-8M | $19M | $5M | $22M | $26M | $13M | $17M | $17M | $8M | $5M | $2M | $-6M | $-13M | $-10M | |
| Interest Expense | · | · | · | · | · | · | · | · | $6M | $3M | · | $3M | $7M | $3M | · | $3M | |
| Interest Income | $1M | $1M | $2M | $3M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $957.0K | $663.0K | |
| Other Non-op | $-5M | $-3M | $23M | $-11M | $-4M | $-9M | $24M | $110.0K | $-18M | $-6M | $-164.0K | $318.0K | $-143.0K | $111.0K | $105.0K | $-207.0K | |
| Pretax Income | $-19M | $-16M | $-21M | $8M | $940.0K | $14M | $8M | $13M | $-2M | $11M | $3M | $2M | $-5M | $-10M | $-18M | $-14M | |
| Income Tax | $-106.0K | $253.0K | $-5M | $-204.0K | $272.0K | $459.0K | $1M | $1M | $323.0K | $264.0K | $2M | $0 | $0 | $0 | · | $0 | |
| Net Income | $-19M | $-17M | $-16M | $8M | $668.0K | $13M | $7M | $12M | $-2M | $11M | $1M | $2M | $-5M | $-10M | $-18M | $-14M | |
| EPS (Basic) | $-0.06 | $-0.05 | $-0.05 | $0.03 | $0.00 | $0.04 | $0.03 | $0.04 | $-0.01 | $0.04 | $0.01 | $0.01 | $-0.02 | $-0.04 | $-0.07 | $-0.06 | |
| EPS (Diluted) | $-0.06 | $-0.05 | $-0.05 | $0.03 | $0.00 | $0.04 | $0.03 | $0.04 | $-0.01 | $0.04 | $0.01 | $0.01 | $-0.02 | $-0.04 | $-0.07 | $-0.06 | |
| Shares (Basic) | 309,191,000 | 308,267,000 | -609,602,000 | 306,806,000 | 304,954,000 | 303,481,000 | -543,995,000 | 274,998,000 | 273,056,000 | 270,356,000 | -531,313,000 | 268,732,000 | 265,626,000 | 263,969,000 | -507,739,000 | 259,300,000 | |
| Shares (Diluted) | 309,191,000 | 308,267,000 | -629,907,000 | 311,638,000 | 311,484,000 | 320,897,000 | -598,638,000 | 284,693,000 | 273,056,000 | 324,733,000 | -586,351,000 | 323,770,000 | 265,626,000 | 263,969,000 | -507,739,000 | 259,300,000 | |
| EBITDA | · | $-2M | · | $19M | $5M | $22M | · | $13M | $17M | $17M | · | $5M | $2M | $-6M | · | $-10M |
बैलेंस शीट 25
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $53M | $53M | $75M | $127M | $57M | $47M | $46M | $62M | $97M | $193M | · | $83M | $86M | $86M | · | $54M | |
| Short-term Investments | $58M | $81M | $96M | $133M | $122M | $134M | $151M | $189M | $151M | $107M | · | $58M | $58M | $80M | · | $111M | |
| Receivables | $43M | $28M | $38M | $17M | $27M | $29M | $12M | $18M | $23M | $20M | · | $22M | $28M | $20M | · | $23M | |
| Inventory | $44M | $49M | $35M | $27M | $28M | $29M | $28M | $27M | $25M | $26M | · | $27M | $25M | $22M | · | $18M | |
| Prepaid Expense | $47M | $40M | $47M | $54M | $44M | $34M | $31M | $31M | $30M | $36M | · | $36M | $33M | $15M | · | $12M | |
| Current Assets | $246M | $251M | $292M | $359M | $279M | $274M | $268M | $328M | $326M | $383M | · | $226M | $230M | $223M | · | $218M | |
| PP&E (Net) | $85M | $83M | $82M | $83M | $83M | $84M | $85M | $85M | $85M | $84M | · | $80M | $70M | $55M | · | $41M | |
| PP&E (Gross) | $203M | $198M | $196M | $195M | $194M | $192M | $192M | $192M | $190M | $186M | · | $182M | $170M | $154M | · | $140M | |
| Accum. Depreciation | $118M | $116M | $114M | $113M | $111M | $109M | $107M | $107M | $105M | $103M | · | $101M | $100M | $100M | · | $99M | |
| Goodwill | $68M | $68M | $68M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $3M | |
| Intangibles | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Other Non-current Assets | $17M | $22M | $20M | $19M | $20M | $28M | $27M | $26M | $16M | $7M | · | $8M | $8M | $16M | · | $17M | |
| Total Assets | $732M | $744M | $792M | $495M | $412M | $410M | $394M | $464M | $444M | $481M | · | $320M | $313M | $298M | · | $294M | |
| Accounts Payable | $11M | $16M | $9M | $7M | $10M | $5M | $7M | $6M | $10M | $7M | · | $17M | $17M | $14M | · | $10M | |
| Accrued Liabilities | $61M | $59M | $65M | $31M | $31M | $40M | $40M | $37M | $41M | $42M | · | $32M | $37M | $33M | · | $30M | |
| Current Liabilities | $143M | $135M | $171M | $109M | $112M | $116M | $82M | $72M | $80M | $100M | · | $96M | $97M | $82M | · | $60M | |
| Capital Leases | $10M | $10M | $11M | $10M | $11M | $11M | $12M | $12M | $3M | $4M | · | $4M | $5M | $5M | · | $6M | |
| Total Liabilities | $800M | $804M | $843M | $539M | $467M | $469M | $473M | $674M | $670M | $711M | · | $572M | $574M | $554M | · | $532M | |
| Long-term Debt | $319M | $319M | $355M | $110M | $36M | $36M | $36M | $228M | $228M | $264M | · | $273M | $274M | $274M | · | $273M | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Retained Earnings | $-3.23B | $-3.21B | $-3.20B | $-3.18B | $-3.19B | $-3.19B | $-3.20B | $-3.21B | $-3.22B | $-3.22B | · | $-3.23B | $-3.23B | $-3.23B | · | $-3.20B | |
| AOCI | $-19.0K | $-4.0K | $115.0K | $137.0K | $1M | $1M | $1M | $588.0K | · | · | · | $443.0K | $443.0K | · | · | $-1M | |
| Stockholders' Equity | $-67M | $-59M | $-51M | $-45M | $-55M | $-59M | $-79M | $-210M | $-226M | $-230M | $-246M | $-252M | $-260M | $-255M | $-251M | $-238M | |
| Liabilities + Equity | $732M | $744M | $792M | $495M | $412M | $410M | $394M | $464M | $444M | $481M | · | $320M | $313M | $298M | · | $294M | |
| Shares Outstanding | 309,911,682 | 308,907,331 | 307,832,587 | 307,027,189 | 306,332,133 | 303,918,969 | 302,959,782 | 275,775,038 | 274,467,247 | 270,801,781 | · | 269,543,539 | 268,235,145 | 264,278,760 | · | 263,156,165 |
नकदी प्रवाह 11
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $6M | $6M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $-427.0K | |
| Stock-based Comp | $10M | $6M | $7M | $4M | $8M | $5M | $6M | $5M | $6M | $4M | $4M | $5M | $6M | $4M | $3M | $4M | |
| Amort. of Intangibles | $4M | $4M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-18M | $-5M | $-8M | $24M | $9M | $-6M | $23M | $9M | $4M | $7M | $22M | $9M | $3M | $1M | $-2M | $-28M | |
| CapEx | $5M | $2M | $2M | $1M | $1M | $330.0K | $3M | $1M | $3M | $2M | $6M | $11M | $17M | $8M | $5M | $271.0K | |
| Investing Cash Flow | $18M | $19M | $-292M | $-25M | $6M | $6M | $48M | $-41M | $-55M | $-48M | $-8M | $-12M | $4M | $14M | $15M | $27M | |
| Financing Cash Flow | $559.0K | $-35M | $247M | $72M | $-6M | $1M | $-87M | $-2M | $-45M | $-3M | $142M | $-283.0K | $-6M | $1M | $3M | $20M | |
| Net Change in Cash | $97.0K | $-22M | $-53M | $70M | $10M | $975.0K | $-16M | $-34M | $-96M | $-45M | $155M | $-3M | $315.0K | $16M | $15M | $19M | |
| Taxes Paid | $753.0K | $63.0K | $549.0K | $80.0K | $869.0K | $207.0K | $2M | $236.0K | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-7M | · | · | · | $-7M | · | · | · | $4M | · | · | · | $-7M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $2M | · | · | · | $-10M | · | · |
लाभप्रदता 7
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -1.8% | · | 23.0% | 6.9% | 28.4% | · | 18.2% | 22.9% | 25.2% | · | 9.9% | 3.5% | -14.8% | · | -29.3% | |
| Net Margin | · | -18.4% | · | 9.7% | 0.87% | 16.8% | · | 16.5% | -2.8% | 16.0% | · | 3.4% | -10.8% | -24.1% | · | -44.0% | |
| Pretax Margin | · | -18.1% | · | 9.5% | 1.2% | 17.4% | · | 18.4% | -2.3% | 16.4% | · | 3.4% | -10.8% | -24.1% | · | -44.0% | |
| EBITDA Margin | · | -1.8% | · | 23.0% | 6.9% | 28.4% | · | 18.2% | 22.9% | 25.2% | · | 9.9% | 3.5% | -14.8% | · | -29.3% | |
| ROA | · | -2.9% | · | 1.7% | 0.16% | 2.9% | · | 2.9% | -0.53% | 2.7% | · | 0.56% | -1.8% | -3.2% | · | -5.4% | |
| ROE | · | 28.2% | · | -6.3% | -0.48% | -9.1% | · | -5.0% | 0.83% | -4.4% | · | -0.70% | 2.1% | 4.0% | · | 6.8% | |
| ROIC | · | 2.9% | · | -43.5% | -6.8% | -36.8% | · | -5.5% | -8.8% | -7.1% | · | -2.0% | -0.66% | 2.4% | · | · |
तरलता और शोधन क्षमता 3
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.9 | · | 3.3 | 2.5 | 2.4 | · | 4.5 | 4.1 | 3.8 | · | 2.3 | 2.4 | 2.7 | · | 3.7 | |
| Quick Ratio | · | 1.2 | · | 2.5 | 1.8 | 1.8 | · | 3.7 | 3.4 | 3.2 | · | 1.7 | 1.8 | 2.3 | · | 3.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | 2.7 | 6.5 | · | 1.8 | 0.3 | -2.5 | · | · |
दक्षता 3
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.4 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.4 | · | 0.4 | |
| Receivables Turnover | 3.1 | 3.2 | · | 4.6 | 3.0 | 3.2 | · | 3.5 | 2.8 | 3.3 | · | 2.3 | 2.3 | 2.8 | · | 2.0 |
मूल्यांकन (TTM) 9
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $358M | $327M | · | $307M | $297M | $287M | · | $260M | $239M | $207M | · | $173M | $141M | $104M | · | $86M | |
| Net Income TTM | $-27M | $5M | · | $33M | $23M | $33M | · | $22M | $5M | $-3M | · | $-28M | $-59M | $-79M | · | $-74M | |
| Market Cap | $1.32B | $757M | · | $1.65B | $1.15B | $1.53B | · | $1.73B | $1.43B | $1.23B | · | $1.11B | $1.09B | $1.08B | · | $813M | |
| P/E | -53.2 | 122.5 | · | 48.8 | 53.4 | 45.7 | · | 78.6 | 261.0 | -453.0 | · | -37.5 | -17.7 | -13.2 | · | -10.7 | |
| P/S | 3.7 | 2.3 | · | 5.4 | 3.9 | 5.3 | · | 6.7 | 6.0 | 5.9 | · | 6.4 | 7.7 | 10.4 | · | 9.5 | |
| P/B | -19.6 | -12.8 | · | -37.0 | -20.8 | -26.1 | · | -8.3 | -6.3 | -5.3 | · | -4.4 | -4.2 | -4.2 | · | -3.4 | |
| P / Cash Flow | · | -141.1 | · | · | · | -239.7 | · | · | · | 183.0 | · | · | · | 937.3 | · | · | |
| P / FCF | · | -104.5 | · | · | · | -227.9 | · | · | · | 285.6 | · | · | · | -151.4 | · | · | |
| Earnings Yield | -1.9% | 0.82% | · | 2.1% | 1.9% | 2.2% | · | 1.3% | 0.38% | -0.22% | · | -2.7% | -5.7% | -7.6% | · | -9.4% |
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
आय विवरण
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| राजस्व | $349M | $286M | $199M | $100M | $75M |
| परिचालन मार्जिन % | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% |
| शुद्ध आय | $6M | $28M | $-12M | $-87M | $-81M |
| तनुकरणित EPS | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 |
बैलेंस शीट
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| वर्तमान अनुपात | 1.7 | 3.3 | 3.6 | 3.5 | 4.5 |
| त्वरित अनुपात | 1.2 | 2.6 | 3.0 | 2.8 | 4.3 |
नकदी प्रवाह
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $14M | $33M | $-8M | $-88M | $-73M |
ताज़ा समाचार इस कंपनी का उल्लेख करने वाली हालिया सुर्खियां
- Wells Fargo Calls MannKind Corporation (MNKD)’s Commercial Potential a “Show-Me Story”
- MannKind (MNKD) Advances Clinical Trials for Inhaled IPF Therapy
- H.C. Wainwright और वेल्स फ़ार्गो ने MannKind (MNKD) के मूल्य लक्ष्यों को बढ़ाया
- क्या MannKind Corporation (MNKD) रॉबिनहुड पर खरीदने के लिए लोकप्रिय पैनी स्टॉक्स में से एक है?
ट्रेडिंग सिग्नल प्रवेश मूल्य और जोखिम/इनाम अनुपात के साथ हालिया खरीद/बिक्री संकेत
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर पूर्ण फंडामेंटल में किसी भी पंक्ति के बगल में ➕ पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
संस्थागत मालिक (13F) 271 फाइलर्स · $560.6M कुल · तिथि अनुसार 30 जून 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 55 (+12 पिछली तिमाही की तुलना में) | 37 (-11 पिछली तिमाही की तुलना में) | 93 (+10 पिछली तिमाही की तुलना में) | 61 (-8 पिछली तिमाही की तुलना में) | +24.2M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| Rubric Capital Management LP | $76680000 | 18000000 | 13.68% | शेयर |
| STATE STREET CORP | $68901423 | 16174043 | 12.29% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $56101610 | 13169392 | 10.01% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $29027881 | 6812460 | 5.18% | शेयर |
| Frazier Life Sciences Management, L.P. | $28116000 | 6600000 | 5.01% | शेयर |
| Deep Track Capital, LP | $25560000 | 6000000 | 4.56% | शेयर |
| WELLINGTON MANAGEMENT GROUP LLP | $23099232 | 5422355 | 4.12% | शेयर |
| 180 WEALTH ADVISORS, LLC | $21126835 | 4959351 | 3.77% | शेयर |
| FMR LLC | $17455563 | 4097550 | 3.11% | शेयर |
| TSP Capital Management Group, LLC | $16923596 | 3972675 | 3.02% | शेयर |
| BRAIDWELL LP | $14732908 | 3458429 | 2.63% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12789240 | 3002169 | 2.28% | शेयर |
| VANGUARD GROUP INC | $11888249 | 2096693 | 2.12% | शेयर |
| TWO SIGMA INVESTMENTS, LP | $11475213 | 2693712 | 2.05% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $11070577 | 2598727 | 1.97% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $9358279 | 2196779 | 1.67% | शेयर |
| BANK OF AMERICA CORP /DE/ | $8689749 | 2039847 | 1.55% | शेयर |
| GOLDMAN SACHS GROUP INC | $6332618 | 1486530 | 1.13% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5030221 | 1180803 | 0.90% | शेयर |
| BlackRock, Inc. | $4766748 | 1118955 | 0.85% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $4486321 | 1053127 | 0.80% | शेयर |
| Caption Management, LLC | $4260000 | 1000000 | 0.76% | पुट ऑप्शन |
| J. Goldman & Co LP | $3478669 | 816589 | 0.62% | शेयर |
| WELLS FARGO & COMPANY/MN | $3473987 | 815490 | 0.62% | शेयर |
| SCOPIA CAPITAL MANAGEMENT LP | $2960534 | 694961 | 0.53% | शेयर |
| Balyasny Asset Management L.P. | $2914296 | 684107 | 0.52% | शेयर |
| TWO SIGMA ADVISERS, LP | $2897166 | 510964 | 0.52% | शेयर |
| VICTORY CAPITAL MANAGEMENT INC | $2771407 | 650565 | 0.49% | शेयर |
| Swiss National Bank | $2502324 | 587400 | 0.45% | शेयर |
| STATE OF WISCONSIN INVESTMENT BOARD | $2177052 | 511045 | 0.39% | शेयर |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2106540 | 494493 | 0.38% | शेयर |
| 1492 Capital Management LLC | $2052136 | 481722 | 0.37% | शेयर |
| Mariner, LLC | $2020189 | 474236 | 0.36% | शेयर |
| MILLENNIUM MANAGEMENT LLC | $1836597 | 431126 | 0.33% | शेयर |
| Schonfeld Strategic Advisors LLC | $1774216 | 416483 | 0.32% | शेयर |
| Squarepoint Ops LLC | $1759644 | 413062 | 0.31% | शेयर |
| Jefferies Financial Group Inc. | $1694202 | 397700 | 0.30% | शेयर |
| ExodusPoint Capital Management, LP | $1666261 | 391141 | 0.30% | शेयर |
| JANE STREET GROUP, LLC | $1658418 | 389300 | 0.30% | कॉल ऑप्शन |
| Man Group plc | $1624023 | 381226 | 0.29% | शेयर |
| RHUMBLINE ADVISERS | $1604647 | 376681 | 0.29% | शेयर |
| IEQ CAPITAL, LLC | $1544607 | 362584 | 0.28% | शेयर |
| CITIGROUP INC | $1499243 | 351935 | 0.27% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1423692 | 334200 | 0.25% | पुट ऑप्शन |
| Bank of New York Mellon Corp | $1422222 | 333855 | 0.25% | शेयर |
| Caption Management, LLC | $1414231 | 331979 | 0.25% | शेयर |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1359221 | 319066 | 0.24% | शेयर |
| ALPS ADVISORS INC | $1330615 | 312351 | 0.24% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1216230 | 285500 | 0.22% | कॉल ऑप्शन |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1029075 | 241567 | 0.18% | शेयर |
| BARCLAYS PLC | $1029062 | 241564 | 0.18% | शेयर |
| Rafferty Asset Management, LLC | $1008640 | 236770 | 0.18% | शेयर |
| BNP PARIBAS FINANCIAL MARKETS | $1002715 | 235379 | 0.18% | शेयर |
| Aaron Wealth Advisors LLC | $1000878 | 234948 | 0.18% | शेयर |
| HSBC HOLDINGS PLC | $998560 | 230881 | 0.18% | शेयर |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $930294 | 379712 | 0.17% | शेयर |
| CITADEL ADVISORS LLC | $928680 | 218000 | 0.17% | कॉल ऑप्शन |
| CITADEL ADVISORS LLC | $898860 | 211000 | 0.16% | पुट ऑप्शन |
| Bruce & Co., Inc. | $831011 | 195073 | 0.15% | शेयर |
| VANGUARD ASSET MANAGEMENT, Ltd | $775060 | 181939 | 0.14% | शेयर |
| MetLife Investment Management, LLC | $766442 | 179916 | 0.14% | शेयर |
| FRANKLIN RESOURCES INC | $755021 | 177235 | 0.13% | शेयर |
| Stonepine Capital Management, LLC | $750000 | 250000 | 0.13% | कॉल ऑप्शन |
| UBS Group AG | $715978 | 168070 | 0.13% | शेयर |
| ALLIANCEBERNSTEIN L.P. | $693375 | 283010 | 0.12% | शेयर |
| MORGAN STANLEY | $651282 | 152883 | 0.12% | शेयर |
| TUDOR INVESTMENT CORP ET AL | $640657 | 150389 | 0.11% | शेयर |
| RAYMOND JAMES FINANCIAL INC | $632009 | 148359 | 0.11% | शेयर |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $613437 | 171372 | 0.11% | शेयर |
| Jain Global LLC | $604673 | 141942 | 0.11% | शेयर |
| KING LUTHER CAPITAL MANAGEMENT CORP | $590457 | 138605 | 0.11% | शेयर |
| Susquehanna Portfolio Strategies, LLC | $574538 | 134868 | 0.10% | शेयर |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $570354 | 133886 | 0.10% | शेयर |
| MERCER GLOBAL ADVISORS INC /ADV | $557723 | 130921 | 0.10% | शेयर |
| PROFUND ADVISORS LLC | $517726 | 121532 | 0.09% | शेयर |
| Invesco Ltd. | $512389 | 120279 | 0.09% | शेयर |
| Vanguard Global Advisers, LLC | $509833 | 119679 | 0.09% | शेयर |
| KLP KAPITALFORVALTNING AS | $491604 | 115400 | 0.09% | शेयर |
| Gotham Asset Management, LLC | $452463 | 106212 | 0.08% | शेयर |
| State of New Jersey Common Pension Fund D | $403171 | 94641 | 0.07% | शेयर |
| State of Wyoming | $403149 | 94636 | 0.07% | शेयर |
| Police & Firemen's Retirement System of New Jersey | $386834 | 90806 | 0.07% | शेयर |
| Amundi | $374310 | 87866 | 0.07% | शेयर |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $373478 | 87671 | 0.07% | शेयर |
| NEW YORK STATE COMMON RETIREMENT FUND | $359966 | 84499 | 0.06% | शेयर |
| ARIZONA STATE RETIREMENT SYSTEM | $344050 | 80763 | 0.06% | शेयर |
| Mitsubishi UFJ Asset Management Co., Ltd. | $338155 | 79379 | 0.06% | शेयर |
| Aquatic Capital Management LLC | $335300 | 78709 | 0.06% | शेयर |
| Rockefeller Capital Management L.P. | $332996 | 78168 | 0.06% | शेयर |
| Vanguard Investments Australia, Ltd. | $314929 | 73927 | 0.06% | शेयर |
| JANUS HENDERSON GROUP PLC | $313658 | 127763 | 0.06% | शेयर |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $312203 | 73287 | 0.06% | शेयर |
| Sequoia Financial Advisors, LLC | $296935 | 69703 | 0.05% | शेयर |
| INTECH INVESTMENT MANAGEMENT LLC | $284653 | 66820 | 0.05% | शेयर |
| COMMONWEALTH EQUITY SERVICES, LLC | $280421 | 65827 | 0.05% | शेयर |
| China Universal Asset Management Co., Ltd. | $262714 | 61670 | 0.05% | शेयर |
| LPL Financial LLC | $260060 | 61047 | 0.05% | शेयर |
| SIMPLEX TRADING, LLC | $258790 | 60749 | 0.05% | शेयर |
| Cetera Investment Advisers | $241546 | 56701 | 0.04% | शेयर |
| Painted Porch Advisors LLC | $227620 | 53432 | 0.04% | शेयर |
कंपनी के अंदरूनी सूत्र 43 इनसाइडर्स · 27 अधिकारी · 18 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Michael Castagna | Chief Executive Officer | 15 जुलाई 2026 M | 2433779 | 1 | 4 | $-990292 |
| Hakan Edstrom | President & CEO | 27 अगस्त 2015 A | 1114340 | 0 | 0 | $0 |
| Christopher B Prentiss | Chief Financial Officer | 15 जुलाई 2026 F | 318668 | 0 | 0 | $0 |
| Juergen Martens | Corporate VP and COO | 27 अगस्त 2015 A | 106539 | 0 | 0 | $0 |
| Dominic Marasco | Pres, Endocrine Business Unit | 15 जुलाई 2026 F | 343398 | 0 | 0 | $0 |
| Sanjay R Singh | EVP Technical Operations | 15 जुलाई 2026 M | 478966 | 0 | 1 | $-94448 |
| Stuart A Tross | Chief People & Workpl Officer | 15 जुलाई 2026 M | 1058142 | 0 | 2 | $-548528 |
| David Thomson | EVP Genl Counsel & Secretary | 15 जुलाई 2026 M | 797554 | 0 | 3 | $-930755 |
| Ajay Ahuja | Chief Medical Officer | 23 मार्च 2026 A | 318200 | 0 | 0 | $0 |
| Lauren M Sabella | EVP Operations | 15 जुलाई 2025 F | 349841 | 0 | 0 | $0 |
| Burkhard Blank | EVP Chief Medical Officer | 15 जुलाई 2025 F | 460791 | 0 | 0 | $0 |
| Joseph Kocinsky | Chief Technology Officer | 27 अगस्त 2022 F | 745233 | 0 | 0 | $0 |
| Alejandro Galindo | EVP Endocrine Business Unit | 28 फ़रवरी 2022 A | 576690 | 0 | 0 | $0 |
| Rosabel Realica Alinaya | VP, IR & Treasury | 27 अगस्त 2020 A | 167119 | 0 | 0 | $0 |
| David M Kendall | Chief Medical Officer | 31 जुलाई 2020 P | 41059 | 0 | 0 | $0 |
| Patrick Mccauley | Chief Commercial Officer | 25 फ़रवरी 2020 A | 83972 | 0 | 0 | $0 |
| Courtney Barton | Chief Compl & Privacy Officer | 31 जुलाई 2019 P | 29584 | 0 | 0 | $0 |
| Elizabeth Garrett Ingram | Chief Marketing Officer | 14 मई 2019 A | 43012 | 0 | 0 | $0 |
| Raymond W. Urbanski | Corp VP, CMO | 10 अगस्त 2017 S | 2924 | 0 | 0 | $0 |
| Linda A Adreveno | Sr. VP, HR | 18 फ़रवरी 2016 A | 92200 | 0 | 0 | $0 |
| Alfred E Mann | Executive Chairman | 22 अगस्त 2015 F | 1005990 | 0 | 0 | $0 |
| Diane Palumbo | Vice President, Human Resource | 23 फ़रवरी 2015 F | 50624 | 0 | 0 | $0 |
| Peter C Richardson | Chief Scientific Officer | 3 मार्च 2012 F | 133611 | 0 | 0 | $0 |
| Richard L Anderson | Corporate VP | 16 नवमबर 2008 F | 204401 | 0 | 0 | $0 |
| John R. Riesenberger | VP & Chief Commercial Officer | 13 अगस्त 2008 A | 14650 | 0 | 0 | $0 |
| Dan Burns | VP & President, MKBP | 8 दिसमबर 2006 A | 14800 | 0 | 0 | $0 |
| Wendell W Cheatham | VP, Medical & Reg Affairs | 19 अगस्त 2004 A | 300 | 0 | 0 | $0 |
| Sabrina Kay | निदेशक | 20 मई 2026 A | 265600 | 0 | 0 | $0 |
| Jennifer Grancio | निदेशक | 20 मई 2026 A | 244815 | 0 | 0 | $0 |
| James Samuel Shannon | निदेशक | 20 मई 2026 A | 64635 | 0 | 0 | $0 |
| Michael A Friedman | निदेशक | 20 मई 2026 A | 47500 | 0 | 0 | $0 |
| Anthony C Hooper | निदेशक | 20 मई 2026 A | 236153 | 0 | 0 | $0 |
| Christine Mundkur | निदेशक | 20 मई 2026 A | 254493 | 0 | 0 | $0 |
| Ronald J Consiglio | निदेशक | 20 मई 2026 A | 132342 | 0 | 0 | $0 |
| Kent Kresa | निदेशक | 15 मई 2024 A | 274541 | 0 | 0 | $0 |
| Henry L Nordhoff | निदेशक | 14 मई 2019 A | 103426 | 0 | 0 | $0 |
| David Maccallum | निदेशक | 16 मई 2018 A | 114790 | 0 | 0 | $0 |
| Matthew J Pfeffer | निदेशक | 28 अगस्त 2017 F | 81961 | 0 | 0 | $0 |
| Abraham E Cohen | निदेशक | 17 अगस्त 2012 S | 56424 | 0 | 0 | $0 |
| Heather Hay Murren | निदेशक | 13 अगस्त 2008 A | 10100 | 0 | 0 | $0 |
| Kathleen Connell | निदेशक | 25 मई 2006 A | — | 0 | 0 | $0 |
| Llew Keltner | निदेशक | 25 मई 2006 A | — | 0 | 0 | $0 |
| Steven B. Binder | — | 7 अगस्त 2026 S | 785867 | 0 | 3 | $-427369 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
कार्यकर्ता और 5%+ मालिक 2 होल्डिंग्स
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| Alfred E. Mann, Alfred E. Mann Living Trust, Biomed Partners, LLC, Minimed Infusion, Inc., The Mann Group LLC ×2 फाइलिंग | 10 जुलाई 2012 | — | प्रारंभिक फाइलिंग | — | SEC |
| अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति | 31 जनवरी 2006 | — | प्रारंभिक फाइलिंग | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ईटीएफ स्वामित्व 41 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| RNIN · EA Series Trust | 1.43% | 773251 NS | 30 अप्रैल 2026 | N-PORT |
| SBIO · ALPS ETF Trust | 0.74% | 317578 NS | 31 मई 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.54% | 29662 SH | 8 अगस्त 2026 | दैनिक |
| AGNG · Global X Funds | 0.46% | 98947 NS | 31 मई 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.34% | 625921 NS | 30 अप्रैल 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0.11% | 64525 NS | 31 मई 2026 | N-PORT |
| IBB · iShares Trust | 0.09% | 2170137 SH | 8 अगस्त 2026 | दैनिक |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.09% | 16814 SH | 8 अगस्त 2026 | दैनिक |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.08% | 330117 SH | 8 अगस्त 2026 | दैनिक |
| IWO · iShares Trust | 0.07% | 2772931 SH | 8 अगस्त 2026 | दैनिक |
| ESML · iShares Trust | 0.06% | 449515 SH | 8 अगस्त 2026 | दैनिक |
| BIB · ProShares Trust | 0.06% | 11389 NS | 31 मई 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.04% | 114273 NS | 30 अप्रैल 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.04% | 1771496 SH | 8 अगस्त 2026 | दैनिक |
| IWM · iShares Trust | 0.04% | 7830029 SH | 8 अगस्त 2026 | दैनिक |
| ISCG · iShares Trust | 0.04% | 94032 SH | 8 अगस्त 2026 | दैनिक |
| ITWO · ProShares Trust | 0.03% | 14400 NS | 31 मई 2026 | N-PORT |
| RSSL · Global X Funds | 0.03% | 132607 NS | 30 अप्रैल 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.02% | 1466402 NS | 31 मई 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.02% | 61465 NS | 31 मई 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.02% | 874372 SH | 8 अगस्त 2026 | दैनिक |
| ISCB · iShares Trust | 0.02% | 13557 SH | 8 अगस्त 2026 | दैनिक |
| UWM · ProShares Trust | 0.02% | 11261 NS | 31 मई 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.01% | 135688 NS | 30 अप्रैल 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.01% | 638128 NS | 30 अप्रैल 2026 | N-PORT |
| URTY · ProShares Trust | 0.01% | 11390 NS | 31 मई 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 3543398 SH | 8 अगस्त 2026 | दैनिक |
| WSML · iShares Trust | 0.01% | 16464 SH | 8 अगस्त 2026 | दैनिक |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 12000 NS | 31 मई 2026 | N-PORT |
| HDG · ProShares Trust | 0.01% | 286 NS | 31 मई 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 452118 NS | 30 अप्रैल 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 27701 NS | 30 अप्रैल 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0.00% | 1330 NS | 31 मई 2026 | N-PORT |
| ITOT · iShares Trust | 0.00% | 465445 SH | 8 अगस्त 2026 | दैनिक |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 196006 NS | 31 मई 2026 | N-PORT |
| IWV · iShares Trust | 0.00% | 83220 SH | 8 अगस्त 2026 | दैनिक |
| TILT · FlexShares Trust | 0.00% | 10345 NS | 30 अप्रैल 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 32093 NS | 30 अप्रैल 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 14557 NS | 30 अप्रैल 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 9327332 SH | 8 अगस्त 2026 | दैनिक |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 26184 SH | 8 अगस्त 2026 | दैनिक |